Patient's preferences for health scenarios associated with hepatitis C and its treatment

Patient Preference and Adherence

Volumn 3, Issue , 2009, Pages 363-370

  Tinè, Fabio ^a  

^a Ospedali Riuniti Villa Sofia Cervello   (Italy)

Author keywords

Antiviral treatment; Decision role; Hepatitis C; Preferences

Indexed keywords

EID: 79957595759     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S7684     Document Type: Article

References (25)

1. World Health Organization. Hepatitis C Fact Sheet. Available from: http://www.who.int/immunization/topics/hepatitis/en/index.html. Accessed on October 10, 2009.
2. Trepo C, Pradat P. Hepatitis C virus infection in Western Europe. J Hepatol. 1999;31:80-83.
3. Seeff LB. Natural history of chronic hepatitis C. Hepatology. 2002;36: S35-S46.
4. Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology. 2007;45: 806-816.
5. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C. N Engl J Med. 2002;347:975-982.
6. Rajendra A, Wong JB. Economics of chronic hepatitis B and hepatitis C. J Hepatol. 2007;47:608-617.
7. Frankael LL, McGraw S, Wongcharatrawee S, et al. What do patients consider when making decisions about chronic hepatitis C? Am J Med. 2005;118:1387-1391.
8. Deber RB, Kraetschmer N, Irvine J. What role do patients wish to play in treatment decision making? Arch Intern Med. 1996;156(13): 1414-1420.
9. Hubbard G, Kidd L, Donaghy E. Preferences for involvement in treatment decision making of patients with cancer: a review of the literature. Eur J Oncol Nurs. 2008;12:299-318.
10. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40:593-600.
11. Eraker SA, Sox HC. Assessment of patient's preferences for therapeutic outcomes. Med Decis Making. 1981;1:29-39.
12. McLermon DJ, Dillon J, Donnan PT, et al. Health-state utilities in liver disease. A systematic review. Med Decis Making. 2008;28: 582-592.
13. Craxi A, Piccinino F, Alberti A, et al. Predictors of SVR in naive HCV1 patients in real life practice: the PROBE. J Hepatol. 2008;48(Suppl 2): S291.
14. Degner LF, Sloan JA, Vankatesh P. The Control Preferences Scale. Can J Nurs Res. 1997;29:21-43.
15. Cotler SJ, Patil R, McNutt RA, et al. Patient's values for health states associated with hepatitis C and physicians' estimates of those values. Am J Gastroenterol. 2001;96:2730-2736.
16. Caress AL, Beaver K, Luker K, et al. Involvement in treatment decisions: what do adults with asthma want and what do they get? Result of a cross-sectional survey. Thorax. 2005;60:199-205.
17. Chamot E, Charvet A, Perneger TV. Women's preferences for doctor's involvement in decisions about mammography. Med Decis Making. 2004;24:379-385.
18. Ende J, Lewis K, Ash A, et al. Measuring patients' desire for autonomy: decision making and information-seeking preferences among medical patients. J Gen Intern Med. 1989;4:23-30.
19. Arora NK, McHorney CA. Patient preferences for medical decision making: who really wants to participate? Med Care. 2000;38:335-341.
20. Ernst J, Brähler E, Aldaoud A, et al. Desired and perceived participation in medical decision-making in patients with haemato-oncological diseases. Leuk Res. 2009 July 20. [Epub ahead of press].
21. Rodriguez KL, Appelt CJ, Switzer GE, et al. Veterans' decision-making preferences and perceived involvement in care for chronic heart failure. Heart Lung. 2008;37:440-448.
22. Froberg DG, Kane RL. Methodology for measuring health-state preferences II: Scaling methods. J Clin Epidemiol. 1989;42:459-471.
23. Chong CA, GulamHussein A, Heathcote JE, et al. Health state utilities and quality of life in hepatitis C patients. Am J Gastroenterol. 2003;98:630-638.
24. Sherman KE, Sherman SN, Chenier T, et al. Health values of patients with chronic hepatitis C infection. Arch Intern Med. 2004;164:2377-2382.
25. Sinclair JC, Cook RJ, Pauker SG, et al. When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum rate for treatment. J Clin Epidemiol. 2001;54:253-262.